Author | Dorothy P. Reddy, MD


Treatment-Resistant Anxiety Disorders: Neurotrophic Perspectives

October 31, 2006


Anxiety disorders are the most prevalent psychiatric disorders in the United States. Although effective treatments are available, such as the SSRIs and cognitive-behavioral therapy (CBT), it is estimated that in about 40% of patients, anxiety disorders are partially or completely resistant to first-line treatment.